Characterization of Inhibitors and Monoclonal Antibodies That Modulate the Interaction between Plasmodium falciparum Adhesin PfRh4 with Its Erythrocyte Receptor Complement Receptor 1.

The Journal of Biological Chemistry
Nicholas T Y LimWai-Hong Tham

Abstract

Plasmodium falciparum parasites must invade red blood cells to survive within humans. Entry into red blood cells is governed by interactions between parasite adhesins and red blood cell receptors. Previously we identified that P. falciparum reticulocyte binding protein-like homologue 4 (PfRh4) binds to complement receptor 1 (CR1) to mediate entry of malaria parasites into human red blood cells. In this report we characterize a collection of anti-PfRh4 monoclonal antibodies and CR1 protein fragments that modulate the interaction between PfRh4 and CR1. We identify an anti-PfRh4 monoclonal that blocks PfRh4-CR1 interaction in vitro, inhibits PfRh4 binding to red blood cells, and as a result abolishes the PfRh4-CR1 invasion pathway in P. falciparum. Epitope mapping of anti-PfRh4 monoclonal antibodies identified distinct functional regions within PfRh4 involved in modulating its interaction with CR1. Furthermore, we designed a set of protein fragments based on extensive mutagenesis analyses of the PfRh4 binding site on CR1 and determined their interaction affinities using surface plasmon resonance. These CR1 protein fragments bind tightly to PfRh4 and also function as soluble inhibitors to block PfRh4 binding to red blood cells and ...Continue Reading

References

Feb 28, 1975·Science·J A DvorakT Shiroishi
Aug 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·J H AdamsL H Miller
Feb 8, 2002·Nature·Louis H MillerOgobara K Doumbo
Dec 4, 2002·The Journal of Experimental Medicine·D C Ghislaine MayerLouis H Miller
Oct 28, 2008·International Journal for Parasitology·Paul R Gilson, Brendan S Crabb
Jun 8, 2010·Malaria Journal·Danny W WilsonJames G Beeson
Jul 28, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michelle J BoyleJames G Beeson
Sep 22, 2010·Proceedings of the National Academy of Sciences of the United States of America·Wai-Hong ThamAlan F Cowman
Oct 22, 2010·The Journal of Immunology : Official Journal of the American Association of Immunologists·Linda ReilingJames G Beeson
Dec 15, 2010·Protein Expression and Purification·Christoph Q SchmidtPaul N Barlow
Jan 22, 2011·Molecular and Biochemical Parasitology·Gordon A AwandareJosé A Stoute
Dec 20, 2011·Trends in Parasitology·Wai-Hong ThamAlan F Cowman
Jun 19, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Kristina E M PerssonJames G Beeson
Jun 19, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Jack S RichardsJames G Beeson
Nov 28, 2013·Nature Communications·Xiaohong GaoPeter R Preiser
Dec 3, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Alexander D DouglasSimon J Draper
Mar 31, 2015·Molecular Immunology·Christoph Q SchmidtWai-Hong Tham

❮ Previous
Next ❯

Citations

Oct 22, 2016·Molecular Microbiology·Yaw AniwehPeter R Preiser
Oct 27, 2016·Immunological Reviews·Christoph Q SchmidtDaniel Ricklin
May 25, 2018·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Jenny U JohanssonJoseph Rogers

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.